Stoke Therapeutics, Inc.
SEC Filing List
STOK CIK: 0001623526
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SCHULTE ROTH & ZABEL LLP /fa | 05/18/2026 | |||
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/15/2026 | |||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | SCHULTE ROTH & ZABEL LLP /fa | 05/15/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Stoke Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 8-K | Current report filing | Stoke Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 4 | Statement of changes in beneficial owner... | Ticho Barry | Stoke Therapeutics, Inc. | 05/05/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 05/01/2026 | ||
| No record found. | |||||
| Load More | |||||
